Genflow Biosciences plc (LON:GENF – Get Free Report)’s stock price traded up 7.9% during trading on Thursday . The company traded as high as GBX 2.05 and last traded at GBX 2.05. 790,856 shares were traded during mid-day trading, a decline of 54% from the average session volume of 1,718,760 shares. The stock had previously closed at GBX 1.90.
Genflow Biosciences Price Performance
The business has a 50-day simple moving average of GBX 1.89 and a 200-day simple moving average of GBX 1.53. The firm has a market capitalization of £10.36 million, a PE ratio of -4.18 and a beta of 2.37.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Stories
- Five stocks we like better than Genflow Biosciences
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
